PRLD stock · QS stock

PRLD vs QS · rev $6.5M vs $5.16B cap

Prelude Therapeutics Inc (PRLD) versus Quantumscape Corp (QS) — a side-by-side from cached financials, not a winner call.

Prelude Therapeutics Inc (PRLD) is a biotechnology company listed on NASDAQ.

Quantumscape Corp (QS) is a auto parts company listed on US.

Latest reported PRLD revenue for 2025-09-30 was $6.5M. Net income was -$83.0M. Revenue was up 116.7% from 2024-09-30 to 2025-09-30. PRLD currently screens at market cap $346.5M.

QS does not have a complete income-statement cache yet.

PRLD currently screens at market cap $346.5M. QS currently screens at market cap $5.16B.

Not investment advice. Open the PRLD and QS stock pages for the full models.

Not investment advice.

Popular Stock Comparisons